# Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis

> **NCT01241214** · PHASE2 · COMPLETED · sponsor: **Idorsia Pharmaceuticals Ltd.** · enrollment: 579 (actual)

## Conditions studied

- Seasonal Allergic Rhinitis

## Interventions

- **DRUG:** ACT-129968
- **DRUG:** ACT-129968
- **DRUG:** Cetirizine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01241214
- **Lead sponsor:** Idorsia Pharmaceuticals Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 579 (ACTUAL)
- **Last updated:** 2019-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01241214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01241214, "Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT01241214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*